Georgia Breast and Cervical Cancer Program (GBCCP) staff Ensure program success through monitoring of Program goals, objectives, funding, reports and data Guide evaluation design and utilize evaluation findings to inform Program activities Georgia Department of Public Health (DPH) Health Departments Deliver GBCCP services, collaborate with local partners and enrollment of eligible women into state’s Women’s Health Medicaid Provide data through qualitative and quantitative collection methods. DPH Evaluation Team Collection, analytics and reporting of program specific data Develop, execute and disseminate evaluation plan. Create recommendations from findings. Related Chronic Disease Programs Strategic partnerships, coordination, and collaboration. Progress toward Departmental goals Provide input on evaluation questions and use findings for successful achievement of respective program goals American Cancer Society (ACS) Client Navigation Program (CNP) Provide patient navigation, outreach and education Provide screening data and previous CNP evaluation data. Participating Primary Care Providers Perform screening, education, follow-up diagnostic evaluation, and case management Provide screening data and information on current policies and activities. Policymakers & Other Government Agencies Enhanced capacity to service constituents Define priorities for evaluation focus Women receiving services through GBCCP Receipt of GBCCP services Provide data. Program Description Breast cancer is the most common cancer diagnosed and the second leading cause of cancer death among women in Georgia. Each year from 2005-2009, an average of 5,800 new cases of female breast cancer were reported to the Georgia Comprehensive Cancer Registry.
Data Collection Evaluation Question Indicators Performance Measure Data Collection Sources Data Collection Frequency What are the facilitating factors and barriers to screening site performance? How will barriers be reduced? Mammograms Provided to Women 50 Years of Age and Pap Smears Provided to Women 21-64 Years of Age Percentage of NBCCEDP funded mammograms provided to women 50 years of age and older and pap smears provided to women 21-64 years of age (goal: >= 75%) Screening Data Patient/Provider Experience Semi Structured Interviews, Site Observation Monthly, Quarterly, Annually To what extent are women screened at each site retained through the completion of their plan of care? Abnormal Screening Results with Complete Follow-Up Percentage of abnormal Pap tests with complete follow-up (goal: >= 90%) Screening Data, Site Observation Monthly, Quarterly, Annually Abnormal Screening Results; Time from Screening to Diagnosis > 90 Days Percentage of abnormal breast screenings with complete follow-up (goal: >= 90%) Screening Data Monthly, Quarterly, Annually Abnormal Screening Results with Complete Follow-Up Percentage of abnormal breast screenings where the time between the screening/referral and final diagnosis was > 60 days (goal: <= 25%) Site Observation Monthly, Quarterly, Annually Abnormal Screening Results; Time from Screening to Diagnosis > 60 Days Percentage of final diagnosis of breast cancer where the time between the date of final diagnosis and the date of treatment initiation is > 60 days (goal: <= 20%) Screening Data Monthly, Quarterly, Annually